BR112014028570A2 - processo para fabricação de compostos de ciclopentilpirimidina hidroxilada. - Google Patents

processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.

Info

Publication number
BR112014028570A2
BR112014028570A2 BR112014028570A BR112014028570A BR112014028570A2 BR 112014028570 A2 BR112014028570 A2 BR 112014028570A2 BR 112014028570 A BR112014028570 A BR 112014028570A BR 112014028570 A BR112014028570 A BR 112014028570A BR 112014028570 A2 BR112014028570 A2 BR 112014028570A2
Authority
BR
Brazil
Prior art keywords
manufacturing
hydroxylated
compounds
cyclopentylpyrimidine compounds
hydroxylated cyclopentylpyrimidine
Prior art date
Application number
BR112014028570A
Other languages
English (en)
Inventor
W Lane Jonathan
l spencer Keith
J Stengel Peter
Shakia Sagar
Remarchuk Travis
Original Assignee
Array Biopharma Inc
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma Inc, Genentech Inc filed Critical Array Biopharma Inc
Publication of BR112014028570A2 publication Critical patent/BR112014028570A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
BR112014028570A 2012-05-17 2013-05-17 processo para fabricação de compostos de ciclopentilpirimidina hidroxilada. BR112014028570A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261648421P 2012-05-17 2012-05-17
US201361785281P 2013-03-14 2013-03-14
PCT/US2013/041624 WO2013173736A1 (en) 2012-05-17 2013-05-17 Process for making hydroxylated cyclopentylpyrimidine compounds

Publications (1)

Publication Number Publication Date
BR112014028570A2 true BR112014028570A2 (pt) 2018-04-24

Family

ID=48534507

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014028570A BR112014028570A2 (pt) 2012-05-17 2013-05-17 processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.

Country Status (19)

Country Link
US (1) US9309204B2 (pt)
EP (1) EP2861583B1 (pt)
JP (1) JP6214636B2 (pt)
KR (1) KR20150020211A (pt)
CN (1) CN104487430B (pt)
AU (1) AU2013262568B2 (pt)
BR (1) BR112014028570A2 (pt)
CA (1) CA2873653A1 (pt)
DK (1) DK2861583T3 (pt)
ES (1) ES2588878T3 (pt)
HK (1) HK1208673A1 (pt)
IL (1) IL235714A0 (pt)
MA (1) MA37649B1 (pt)
MX (1) MX2014013865A (pt)
PL (1) PL2861583T3 (pt)
RU (1) RU2014151017A (pt)
SG (1) SG11201407613RA (pt)
SI (1) SI2861583T1 (pt)
WO (1) WO2013173736A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169028A (en) 2012-05-17 2019-02-04 Genentech Inc Process for making hydroxylated cyclopentylpyrimidine compounds
RU2642311C2 (ru) 2012-05-17 2018-01-24 Дженентек, Инк. Способ получения гидроксилированных циклопентапиримидиновых соединений и их солей
DK2858989T3 (da) 2012-05-17 2020-06-02 Genentech Inc Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil
MX350443B (es) 2012-05-17 2017-09-06 Genentech Inc Proceso para hacer compuestos de aminoácidos.
BR112016011048A8 (pt) 2013-11-15 2020-04-22 Hoffmann La Roche processo para preparar um composto, processos para fabricar compostos, compostos e composições farmacêuticas
ES2688600T3 (es) * 2013-11-27 2018-11-05 Sunshine Lake Pharma Co., Ltd. Procesos para preparar derivados de dihidropirimidina e intermedios de los mismos
RU2732404C2 (ru) * 2014-09-26 2020-09-16 Ф. Хоффманн-Ля Рош Аг СПОСОБЫ ПОЛУЧЕНИЯ (ЦИКЛОПЕНТИЛ[d]ПИРИМИДИН-4-ИЛ)ПИПЕРАЗИНОВЫХ СОЕДИНЕНИЙ
KR20230011368A (ko) 2020-06-16 2023-01-20 에프. 호프만-라 로슈 아게 하이드록실화 사이클로펜틸피리미딘 화합물 제조 방법
KR20230035773A (ko) * 2021-09-06 2023-03-14 연세대학교 산학협력단 Akt 신호경로 억제제를 유효성분으로 포함하는 아토피피부염의 예방 또는 치료용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9408197A (pt) 1993-12-12 1997-08-26 Agrogene Ltd Método para proteger plantas contra doenças fúngicas
EP0973396A4 (en) 1997-04-07 2001-02-07 Merck & Co Inc METHOD FOR TREATING CANCER
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
WO2000052134A2 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
EP1188754B1 (en) 1999-06-03 2005-06-01 Teikoku Hormone Mfg. Co., Ltd. Substituted pyrazole compounds
AU7715300A (en) 1999-09-27 2001-04-30 Merck & Co., Inc. Method of preventing osteoporosis
US7582766B2 (en) 2003-06-09 2009-09-01 Boehringer Ingelheim International Gmbh Inhibitors of papilloma virus
BRPI0416852A (pt) 2003-11-21 2007-02-27 Array Biopharma Inc inibidores da quinase akt
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
US8063050B2 (en) * 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
UA95641C2 (en) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Hydroxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
JP5157576B2 (ja) 2007-05-14 2013-03-06 住友化学株式会社 光学活性2−アルキル−1,1,3−トリアルコキシカルボニルプロパンの製造方法
EP2173723B3 (en) 2007-07-05 2014-11-19 Array Biopharma Inc. Pyrimidyl cyclopentanes as akt protein kinase inhibitors
US20100298289A1 (en) 2007-10-09 2010-11-25 Ucb Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
EP2247578B1 (en) 2008-01-09 2013-05-22 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
US8748462B2 (en) * 2008-10-15 2014-06-10 Amgen Inc. Spirocyclic GPR40 modulators
WO2010120935A1 (en) 2009-04-15 2010-10-21 Abbott Laboratories Anti-viral compounds
ES2465094T3 (es) 2009-10-23 2014-06-05 Eli Lilly And Company Inhibidores de AKT
US9050334B2 (en) 2010-07-16 2015-06-09 Innov88 Llc MIF inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
MY169028A (en) 2012-05-17 2019-02-04 Genentech Inc Process for making hydroxylated cyclopentylpyrimidine compounds
RU2642311C2 (ru) 2012-05-17 2018-01-24 Дженентек, Инк. Способ получения гидроксилированных циклопентапиримидиновых соединений и их солей
MX350443B (es) 2012-05-17 2017-09-06 Genentech Inc Proceso para hacer compuestos de aminoácidos.
US20140121193A1 (en) 2012-11-01 2014-05-01 Robert S. Katz Methods for treating fibromyalgia
CN105263910A (zh) 2013-02-18 2016-01-20 斯克利普斯研究所 具有治疗潜力的血管加压素受体调节剂
CA2904662A1 (en) 2013-03-15 2014-09-25 Shifa Biomedical Corporation Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Also Published As

Publication number Publication date
MA37649B1 (fr) 2017-03-31
CN104487430B (zh) 2016-08-24
DK2861583T3 (en) 2016-10-03
SI2861583T1 (sl) 2016-10-28
KR20150020211A (ko) 2015-02-25
ES2588878T3 (es) 2016-11-07
JP2015518837A (ja) 2015-07-06
AU2013262568B2 (en) 2017-08-31
EP2861583A1 (en) 2015-04-22
US9309204B2 (en) 2016-04-12
AU2013262568A1 (en) 2015-01-22
MX2014013865A (es) 2015-05-07
IL235714A0 (en) 2015-02-01
PL2861583T3 (pl) 2016-12-30
EP2861583B1 (en) 2016-06-29
HK1208673A1 (en) 2016-03-11
CN104487430A (zh) 2015-04-01
CA2873653A1 (en) 2013-11-21
JP6214636B2 (ja) 2017-10-18
MA37649A1 (fr) 2016-06-30
SG11201407613RA (en) 2015-01-29
US20150099881A1 (en) 2015-04-09
RU2014151017A (ru) 2016-07-10
WO2013173736A1 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
BR112014005322A2 (pt) processo
BR112014015994A2 (pt) processo.
BR112014026802A2 (pt) processo para a preparação de um a, \omega-cn diol.
BR112013016198A2 (pt) processo integrado para produção de biocombustíveis
BR112014012414A2 (pt) processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
BR112014015996A2 (pt) processo
BR112014028570A2 (pt) processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.
BR112015003101A2 (pt) processo para a preparação de um composto.
BR112013018945A2 (pt) processo para a preparação de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos.
BR112014026796A2 (pt) processo
BR112014028589A2 (pt) processo para fabricação de compostos de ciclopentilpirimidina hidroxilada
BR112013030546A2 (pt) processo de extrusão.
BR112013030423A2 (pt) método para produção de biocoque
BR112014016001A8 (pt) processo
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BR112015002912A2 (pt) processo para a produção de benzoxazinonas
BR112014015988A8 (pt) processo
BR112013033184A2 (pt) processo
BR112015021297A2 (pt) um processo para a produção de adenovírus.
BR112013018942A2 (pt) processo para o preparo de 4-amino-3-cloro-5-fluro-6(substituído) picolinatos.
BR112014015999A2 (pt) processo
BR112014023401A2 (pt) método para produzir batoque de perfuração-laminação
BR112016010223A2 (pt) processo para a preparação de iopamidol.
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis
BR112014028585A2 (pt) processo para fabricação de compostos de aminoácido.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]